Despite growing support for greater price transparency, US hospitals were worse at providing price estimates for total hip arthroplasty (THA) in 2016 than they were in 2011-2012, a follow-up survey of 120 facilities reports.
"Our results provide sobering evidence that substantial efforts from government and industry to improve pricing transparency have had little tangible effect on availability of prices," write Safiyyah Mahomed, BSc, a medical student at the University of Toronto, Ontario, Canada, and colleagues in a JAMA Internal Medicine research letter published online May 29.
